-
New in the Library (August-September 2024)
Here are the latest items added to the CTN Dissemination Library for August – September 2024 (this post will be updated as new items come in): Barriers and Facilitators to Implementing Treatment for Opioid Use Disorder in Community Hospitals. Shearer R, et al. Journal of Substance Use and Addiction Treatment 2024 (in press). (CTN-0098) A Scoping Review of Social Determinants of Health’s Impact on Substance Use Disorders Over the Life Course. Lin C, et al. Journal of Substance Use & Addiction Treatment 2024 (in press). Impact of COVID-19 on MOUD Retention in a Sample of Rural Primary Care Patients: A Secondary Analysis of Electronic Health Records. Calhoun S, et al.…
-
News from the PNW Node: Videos & Factsheets about XR-Injectable Buprenorphine
Buprenorphine is one of three medications (methadone and naltrexone being the other two) approved for use to treat opioid use disorder. It is available as a film or tablet, and more recently as two long-acting extended-release injectables. Sublocade™ was first to be approved by the FDA in November 2017. More recently, in May 2023, Brixadi™ received approval. In January 2024 it was added to the WA state Medicaid formulary. Fewer clinicians have experience using Brixadi™ than Sublocade™. The CTN Pacific Northwest Node has developed a set of videos and information sheets to help prescribers in their conversations with patients interested in these buprenorphine options. The videos (which are also available in an audio-only podcast format)…
-
News from the New England Consortium
Shelly F. Greenfield, M.D., M.P.H. was selected for the class of 2024-2025 in the Harvard Radcliffe Institute Fellowship. Through this Fellowship, Dr. Greenfield will devote time exploring gender-specific longitudinal trends in substance use disorders. Congratulations Dr. Greenfield on this exciting and prestigious Fellowship opportunity! Read more about this year’s Harvard Radcliffe Institute Fellowships here!
-
NIDA CCTN Seeking Health Scientist Administrator (Program Officer)
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is seeking candidates for a Health Scientist Administrator (Program Officer GS-12/13/14) position. The health scientist administrator will provide scientific leadership and collaborate with NIDA Clinical Trials Network (CTN) investigators in the conception, design, development, conduct, and monitoring of clinical trials and other research studies, as well as provide guidance and assistance in the dissemination of research findings. Desired qualifications of candidates include expertise in behavioral, pharmacological, or integrated therapies for substance use/substance use disorders (SUDs), experience in the management of clinical trials, and expertise in implementation science. Expertise in increasing access to SUD medication treatment through collaboration with health systems…
-
News from the Greater Southern California Node
Upcoming Telehealth (TH) & Telemedicine (TM) Special Interest Group (SIG) on 09/13/2024 @ 8:30am PT/11:30am ET (see flyer attached for additional information) Publication announcements:
